Vimarsana
Biggest News Aggregation in the World

Page 4 - Vasculitis Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vasculitis Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vasculitis Foundation Today - Breaking & Trending Today

Ashton Kutcher's vasculitis, a rare autoimmune disorder: What is it? - Vimarsana News

Ashton Kutcher's vasculitis, a rare autoimmune disorder: What is it?

Actor Ashton Kutcher disclosed a recent bout with an autoimmune condition that affected his hearing, vision and ability to walk. Here's more about vasculitis — and how it affects the blood vessels.

Just In Time: Shortness of breath led Saskatchewan man to rare disease diagnosis - Vimarsana News

Just In Time: Shortness of breath led Saskatchewan man to rare disease diagnosis

Microscopic polyangilitis is a rare autoimmune disease that has a 5-month survival rate if left untreated.

Kawasaki Disease Guideline Highlights Rheumatology Angles - Vimarsana News

Kawasaki Disease Guideline Highlights Rheumatology Angles

The guideline acts "as an adjunct to the already existing and excellent American Heart Association guidelines by adding information in areas that rheumatologists may play a role."

New Kawasaki Disease Guideline Released by American College of Rheumatology and Vasculitis Foundation - Vimarsana News

New Kawasaki Disease Guideline Released by American College of Rheumatology and Vasculitis Foundation

The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released a new guideline for the management of Kawasaki disease

ChemoCentryx, Inc.: ChemoCentryx Announces FDA Approval of TAVNEOS (avacopan) in ANCA-Associated Vasculitis - Vimarsana News

ChemoCentryx, Inc.: ChemoCentryx Announces FDA Approval of TAVNEOS (avacopan) in ANCA-Associated Vasculitis

-- First FDA-approved orally-administered inhibitor of the complement 5a receptor -- -- Company to hold conference call at 8:30 a.m. Eastern Time -- SAN CARLOS, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE)